GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 366 filers reported holding GLOBUS MED INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219,254 | -48.5% | 4,416 | -38.2% | 0.03% | -52.5% |
| Q2 2023 | $425,532 | -15.6% | 7,147 | -19.7% | 0.06% | -13.2% |
| Q1 2023 | $504,379 | +40.5% | 8,905 | +39.1% | 0.07% | +112.5% |
| Q2 2022 | $359,000 | -60.3% | 6,400 | -47.8% | 0.03% | -59.0% |
| Q1 2022 | $905,000 | +38.8% | 12,271 | +35.8% | 0.08% | +56.0% |
| Q4 2021 | $652,000 | +124.8% | 9,035 | +92.0% | 0.05% | +138.1% |
| Q1 2021 | $290,000 | -50.4% | 4,706 | -52.6% | 0.02% | -41.7% |
| Q4 2019 | $585,000 | -57.4% | 9,934 | -85.1% | 0.04% | +16.1% |
| Q3 2015 | $1,373,000 | +28.4% | 66,469 | +59.6% | 0.03% | +10.7% |
| Q2 2015 | $1,069,000 | +33.1% | 41,641 | +2.1% | 0.03% | +33.3% |
| Q3 2014 | $803,000 | -58.1% | 40,800 | -49.1% | 0.02% | -58.8% |
| Q2 2014 | $1,916,000 | +235.0% | 80,117 | +272.6% | 0.05% | +264.3% |
| Q1 2014 | $572,000 | +41.9% | 21,500 | -6.8% | 0.01% | +27.3% |
| Q3 2013 | $403,000 | +79.9% | 23,081 | +73.5% | 0.01% | +83.3% |
| Q2 2013 | $224,000 | – | 13,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |